Somnarus Inc.

Somnarus Inc. is a medical diagnostic company whose innovative products address the significant unmet need of patients with obstructive sleep apnea. With 50 million Americans at risk for sleep apnea and the average medical insurance reimbursement rate of $160 per test, Somnarus is entering the market, whose potential is estimated at $8B. Only SomnaPatch™ product combines accuracy and the ease-of-use with guaranteed medical insurance reimbursement and the convenience of in-home delivery.
Somnarus is seeking to raise $1M to fund its operations for one year to complete product development, to further intellectual property protection, and to conduct a clinical trial for regulatory approval.